Appeal No. 2004-1040 Page 13 Application No. 09/770,643 Subsequent references (GenBank NM_130773 and AB077881) by others do teach proteins which are 99% identical to that of the claimed invention. These proteins are named “Caspr” proteins and are members of the neurexin superfamily. . . . While it is known, as Applicants disclose in the specification, that the superfamily of neurexins mediate neuronal processes, the specific neur[on]al processes of the proteins and genes of the present invention have not been disclosed. . . . Therefore, one of ordinary skill in the art would not know how to use a protein, or a gene, which is only known to generally be involved in neuronal processes, along with potentially hundreds or thousands of proteins. Appellants argue that the claimed nucleic acids encode a protein that would be accepted as a caspr by those skilled in the art, because two sequences sharing nearly 100% percent identity at the protein level over the entire length of the claimed sequence are present in the leading scientific repository for biological sequence data (GenBank), and have been annotated by third party scientists wholly unaffiliated with Appellants as “Homo sapiens caspr5 protein.” . . . Given these GenBank annotations, there can be no question that those skilled in the art would clearly believe that Appellants’ sequence is a caspr protein. Appeal Brief, pages 4-5. Appellants cite sequence comparison data that purportedly show that “caspr proteins are distinct members of the neurexin superfamily,” id., page 5, and conclude that, “[a]s the Examiner admits that casprs have a specific utility, due to their association with ‘myelinated axons and potassium channels’ (the Final Action at page 3), the claimed sequence clearly meets the requirements of 35 U.S.C. § 101.” Id., page 6. We do not agree that the characterization of the claimed nucleic acids as encoding a contactin-associated protein (caspr) is sufficient to establish their utility. The specification admits that “[n]eurexins have been associated with, inter alia, mediating neural processes, seizures, signaling, exocytosis, cancer, and development. Neurexins can also serve as receptors for latrotoxins.” Page 1. The specification does notPage: Previous 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 NextLast modified: November 3, 2007